Bringing Clinical Trials Into The Community – Live With Dan Henley, VCTC Co-founder

Participation in clinical trials is not as easy as it could, or should, be – for both sites and patients. The myriad of challenges faced by patients when it comes to trial participation are not new, however, the industry has been slow to adapt and change both how and, critically, where clinical trials are being conducted.

Sites are also struggling, often carrying the dual responsibility of conducting clinical research while still operating as a local healthcare facility (for example, as a hospital or clinic). This immediately puts additional pressure on healthcare providers that are often already stretched to the limit.

To compound these barriers to participation further, is the fact that trials in different therapeutic indications are very rarely run in multiple sites across a country. Often, trials are offered at centralised sites that are based in some major cities. Further, site selection is unlikely to include two cities that may be close to one another – with sponsors or healthcare trusts opting for one site per region.

In this podcast, Dan Henley, co-founder of VCTC, discusses these challenges – expanding on the experiences of both patients and sites when participating in trials that utilise a traditional model to conduct clinical research.

Giving clear insights into these challenges, especially the ones faced in the UK and Europe, provides the opportunity to then assess the potential solutions that make sense for both patients and sites. Taking it further, Dan delves into how VCTC supports sites and patients through their approach. This includes:

• Providing variations on what and where a “typical” clinical site is
• Pairing patients with trials – and bringing the trial to the patient
• Placing trials – across a broad range of therapeutic indications - in the heart of communities.

Take me to the podcast so I can learn more: Full Podcast